Lymphocyte predominance Hodgkin's disease (LPHD) is a clinically indolent condition. Although there is evidence that the putative neoplastic cell in this disease, the "WH" cell, is of B-cell lineage, there is conflicting data concerning the clonality of these cells. Our study was aimed at clarifying the issue of lineage and clonality of the L&H cells of LPHD using a single-cell assay. Four cases of LPHD were studied. To circumvent the difficulties of obtaining fresh tissue and to be able t o study representative cases, a new method was developed to obtain single-cell suspensions of L&H cells from archival formalin-fixed paraffin-embedded tissue. Single L&H cells were identified by morphology and immunostaining for epithelial membrane antigen, isolated using a micropipette, and subjected to polymerase chain reaction YMPHOCYTE predominance Hodgkin's disease (LPHD) represents approximately 5% to 10% of all cases of HD and is a clinically indolent disorder that mainly affects men. Patients with LPHD usually present with stage I or I1 disease and the condition often remains stable for years, even without treatment. Histologically, LPHD resembles the other subtypes of HD by the presence of scattered large atypical cells, the Reed-Stemberg cells and their variants, admixed with a variety of inflammatory cells. Based on the architecture of the affected lymph node, nodular and diffuse variants of LPHD are recognized. The Reed-Stemberg cell variant and putative neoplastic cell of LPHD, the "L&H" cell, has a large polylobated nucleus, small nucleoli, and a small amount of cytoplasm, which distinguish this cell from the so-called "diagnostic Reed-Stemberg cell" that is present in the other subtypes of HD. In the last decade, with the development of novel antibodies and the improvement of immunohistochemical techniques, a number of investigators have shown that the L&H cell expresses several B-cellassociated molecules and, therefore, may be of B-cell lineage."' However, the question of whether LPHD represents a monoclonal or a polyclonal B-cell disorder remains unresolved. Southern blot analysis and, more recently, polymerase chain reaction (PCR) analysis of DNA extracts of tissues involved by LPHD have not shown clonal Ig gene rearrangements in most studies.'&17 However, such results are not conclusive because these techniques can only detect a monoclonal population that constitutes at least 1% of the total cell population in the tissues; the number of L&H cells in most cases of LPHD is below the threshold of detection when the Southern blotting technique is Although the PCR technique is very sensitive when clone-specific primers are used for amplification, detection of clonal rearranged Ig genes using consensus primers is far less sensitive because the products of a small clonal population may be obscured by those deriving from the numerous nonneoplastic B cells also present in the tissues." In situ analysis of Ig light chain protein or mRNA expression, which provide conclusive evidence for the monoclonality of most B-cell (PCR) amplification of the complematarity determining region 3 (CDR3) of the Ig heavy chain (IgH) gene, which is Bcell clone-specific. The PCR products were size-fractionated by polyacrylamide gel electrophoresis and representative products were directly sequenced. Single T cells and small B cells were also isolated from the tissues and used as negative and positive controls, respectively. In all four cases of LPHD, the IgH CDR3 of single L&H cells could be amplified. Within each case, the IgH CDR3 of single L&H cells was found to be of different length or of different sequence. Therefore, our results provide strong evidence for the B-cell origin of the L&H cells and the polyclonal nature of LPHD. 0 1994 by The American Society of Hematology.
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lymphomas, have yielded conflicting results with respect to the clonality of the L&H cells of LPHD. [21] [22] [23] [24] To confirm the B-cell origin and to shed more light on the issue of clonality of the L&H cell of LPHD, a highly sensitive single-cell assay was developed. To allow the study of a number of cases representative of the disease and to have better morphologic preservation of single cells, a method was developed to isolate single L&H cells from readily available formalin-fixed, paraffin-embedded tissue. We then used a PCR technique to detect Ig heavy chain (IgH) gene V-D-J rearrangements in single L&H cells. The PCR products that comprise the CDR3 were then compared to assess the identity of the VDJ rearrangements.
MATERIALS AND METHODS

Materials
Patients diagnosed with LPHD were selected from the files of the Lymphoma Registry at the University of Nebraska Medical Center. We selected four cases with the following characteristics for the study. First, the morphology of the lymph node was considered typical of either nodular (cases no. 1 and 3) or diffuse LPHD (cases no. 2 and 4) by three of the authors (W.C.C., D.D.W., and J.D.). Second, the L&H cells expressed epithelial membrane antigen (EMA), as evaluated by immunohistochemistry on formalin-fixed, paraffin-embedded tissue. EMA has previously been reported to be expressed by L&H ~e l l s *~~*~ and was a useful L&H cell marker in this study because, with the exception of a few EMA-expressing plasma cells, it was exclusively expressed by L&H cells in the diseased tissues. Two control cases of LPHD were also selected in which the L&H cells did not express EMA. Third, a 280-bp fragment of the &tubulin gene could be amplified from DNA extracts of each case. This product is longer than the expected amplified IgH CDR3 product using our primers, thus assuring that the formalin-fixed, paraffin-embedded tissues contained DNA that was not extensively degraded and was useful to our studies. Finally, only those cases of which frozen tissue samples were also available for the purpose of DNA extraction and Southern blotting were selected for this study.
Immunohistochemistry
Five-micron paraffin sections and 4-pm cryostat sections were cut and stained with a three-step, peroxidase-labeled method." After dewaxing and before staining. paraffin-embedded tissue sections were heated in citrate buffer for 5 minutes using a microwave oven. Cryostat sections were fixed for 10 minutes in acetone before staining. The primary antibodies antileucocyte common antigen (anti-CD45). L26 (anti-CDZO), polyclonal anti-K Ig light chain, polyclonal anti-A Ig light chain. BerH2 (anti-CD30). and anti-EMA were purchased from Dako Corp (Carpinteria. CA) and anti-LeuMI (anti-CD15) was purchased from Becton Dickinson (San Jose, CA). These antibodies were used for staining paraffin-embedded sections. The antibodies anti-Leu12 (anti-CD19) and anti-Leu14 (anti-CD22) were also obtained from Becton Dickinson and were applied to the cryostat sections.
Southern Blot Analysis
ting. and probing was performed as previously described.'x DNA extraction from frozen tissue samples, electrophoresis. blot-
Single-Cell Suspension
Fifty-micron paraffin sections were cut. The knife of the microtome was extensively cleaned before cutting a new paraffin block. The tissue was put in a microfuge tube, dewaxed in xylene and alcohol, and rehydrated in phosphate-buffered saline (PBS; pH 7.4). To obtain a single-cell suspension, the tissue was subsequently digested with a mixture of collagenase (0.3%, type 11; Sigma, St Louis, MO) and trypsin (0.25%. type XI; Sigma) dissolved in PBS (pH 7.4). The digestion was performed for 16 hours at room temperature in a I mL volume using microfuge tubes. The remaining undigested tissue was removed with a pipette tip. The cell suspension was washed twice by pelleting the cells with an Eppendorf centrifuge 5415C (Brinkmann Instruments Inc. Westbury, NY) at 5,000 rpm for IO minutes and then resuspending the cells in PBS. were manually drawn into a glass micropipette. To control that no other cells were submitted for PCR amplification. the cell was ejected into another Petri dish that contained only sterile PBS. Subsequently, the cell was drawn into a new glass micropipette and observed with the inverted microscope for the absence of any other contaminating cells (Fig 2) . The cell was then dropped into 25 pL of PCR buffer containing 200 pglmL of proteinase K (GIBCO BRL, Gaithersburg, MD). Finally, the micropipette was again inspected with the inverted microscope to ascertain that the cell had cleared the pipette. All single cells were selected after inspection and approval by two of the authors (A.T. and J.D.).
PCR AmpliJcation
The IgH CDR3 of DNA of single cells, as well as dewaxed paraffin-embedded tissue sections, of the four cases of LPHD was amplified using a seminested PCR method, thus assuring specificity of the amplified products. In both PCR rounds, a consensus primer to the 3' end of the third framework region of the V, genes was For personal use only. on October 30, 2017. by guest www.bloodjournal.org From performed for 30 cycles and the second round consisted of 35 cycles. Two microliters of a 11400 dilution of the PCR products from the first round was used as the template for the second round of PCR. All reactions were performed using an OmniGene thermocycler (Hybaid Ltd. UK). Positive controls consisted of DNA extracted from the Namalwa B-cell line; negative controls consisted of sterile water. Both controls were included with each set of reactions performed. To test whether falsepositive or false-negative results were produced by the isolation and staining procedures of the single cells, single T cells and single B cells isolated from the same tissues of LPHD were used as negative and positive controls. respectively. using the same reaction conditions. These reactions also included a positive control (Namalwa DNA) and a negative control (sterile water).
DNA was also extracted from one S-pm dewaxed, paraffin-embedded tissue section from each of the four cases of LPHD according to the method of Wright and Manos" and was subsequently submitted for IgH CDR3 amplification. Ten microliters of all PCR products was electrophoresed on 8% polyacrylamide gels and visualized with UV light after ethidium-bromide staining.
IgH CDR3 PCR products of all L&H cells of case no. I and those of similar length obtained from case no. 3 (cells L2A6 and LZC8) and case no. 4 (cells L5A3 and L5A7) were sequenced to determine the IgH CDR3 identity. For this purpose. the second round of IgH CDR3 PCR was repeated in a 1 0 0 pL volume. according to the method described above. The products were gel-purified and submitted for direct sequencing. Automated direct sequencing was performed using the same V,, and JH primers as described above for the second round of IgH CDR.? amplification and fluorescent dideoxynucleotide terminators as previously described." using the Applied Biosystems 373A sequenator (Applied Biosystems, Foster City. CA)
RESULTS
Irnrnunnhistochernistn and Southern Blot Analysis
The results of these studies are summarized in Table 1 . L&H cells expressed one or more B-cell surface antigens in all four cases. The presence of K and A Ig light chains was detected on the cytoplasmic membrane of small B cells in all four cases. L&H cells contained cytoplasmic K and A Ig light chains but whether only one of both of these proteins were present in a single cell could not be assessed with certainty. No clonal Ig gene rearrangements were detected in the Southern blots of the four cases studied.
PCR AmpliJicntion of the IgH CDR3 From Single Cells and Tissue Sections
The PCR products obtained from DNA extracts of tissue sections from the four cases of LPHD appeared as smears in the 100-bp range when electrophoresed. Such smears are typical of the presence of a polyclonal B-cell population. No prominent discrete bands indicative of a dominant B-cell clone were observed (Fig 3) .
The number of positive results obtained for the single cells analyzed from each case are summarized in Table 2 . 
Seqlrer~cirtg of PCR Prochccts
We have sequenced one of the IgH CDR3 PCR products of all cells of case no. I and those of the other cases that appeared to comigrate when electrophoresed on regular polyacrylamide gels. The former was performed to confirm that IgH CDR3 products derived from L&H cells and that migrated differently in the gels were composed of an entirely different sequence and. thus. were not clonally related. IgH CDR3 products that migrate differently in routine polycarylamide gels could potentially belong to one B-cell clone that replaces its V,, gene, such as occurs in B-cell precursor leukemia:" Sequence analysis of comigrating IgH CDR3 PCR products was performed because these products could potentially have homologous or, in the case of somatic point mutations, almost homologous sequences and therefore might have belonged to clonally related L&H cells. Somatic point mutations affecting one B-cell clone, such as those occurring in the germinal center and follicular lymphomas . . result in a variable number of nucleotide substitutions that do not affect the migration of the IgH CDR3 PCR products in regular polyacrylamide gels.
The sequences of analyzed products are given in Table 3 . The 10 sequences are composed of unique combinations V, D, and J segments and contain a variable number of N nucleotides. as expected for IgH CDR3 sequences. None of the sequences obtained in any one case shows significant homology. Therefore, these sequence data do not provide evidence for a clonal origin of the analyzed L&H cells. Surprisingly, in two assays of single L&H cells. but in none of the single B-cell assays, three distinct bands indicative of three IgH gene rearrangements were observed. Although contamination in PCR amplifications can never be formally ruled out, the fact that all T-cell and water controls The apparent K Ig light chain restriction, but lack of A Ig light chain restriction, in the L&H cells of all of the cases studied by Schmid et al?* could be explained by differences in the sensitivity of the primary antibodies or differential unmasking of antigens in their tissues and, therefore, may not be indicative of monoclonality. Hell et a124 have recently reported restricted expression of Ig light chain mRNA in four of nine cases of LPHD using an in situ hybridization technique and a large cocktail of oligonucleotide probes for both K and A light chains. However, others have been unable to show the presence of Ig light chain mRNA using a similar technique.23 Although the use of a cocktail of numerous oligonucleotide probes may increase the sensitivity of the technique, it may also increase the possibility of nonspecific hybridization, which may account for the results obtained by Hell et al.= Further studies are needed to clarify these issues.
In the present study of four cases of LPHD, two cases (cases no. 2 and 4) represented the diffuse variant of the disease. There is as yet lack of agreement as to whether the diffuse variant of LPHD, particularly those cases in which the L&H cells express the classical Hodgkin's cell marker CD15, should be included with the nodular variant of LPHD. Some studies have shown that cases of "LPHD" with a diffuse pattern and a classical Reed-Sternberg cell phenotype clinically behave like other subtypes of HD,47,48 whereas others have not confirmed this finding.49-5' Our study suggests that both the diffuse and nodular variants of LPHD, at least those with a B-cell immunophenotype, represent a polyclonal B-cell disorder and may represent a single biologic entity. However, more cases of both nodular and diffuse variants of LPHD will need to be studied with our single-cell assay to fully establish the relationship between these variants of LPHD.
Although we have provided strong evidence that LPHD is a polyclonal B-cell lymphoproliferative disorder, the cause of the disease and the role and function of the L&H cell are unknown. It is of interest that another form of lymphadenopathy of unknown cause, so-called "progressive transformation of germinal centers" (PTGC), mimics the histology of LPHD except for the absence of L&H cells.j2 In addition, both PTGC and LPHD result in localized lymphadenopathy that tends to recur, but usually does not progress.53 In a small percentage of cases, PTGC and LPHD are a s s~c i a t e d ,~~,~~ either synchronously or metachronously, which supports the hypothesis that the two diseases may be part of a spectrum of a peculiar, lymphoproliferative process. The recognition of LPHD as a polyclonal B-cell disorder in addition to the well-known indolent clinical course of the disease discussion may lead to reevaluation of current modes of treatment.
